Snake venom-inspired approach could address unmet medical need

Dutch biotech company VarmX has announced the publication in Nature Communications of a study on a safe and effective reversal agent for prevention and treatment of bleeding in patients taking factor Xa oral anticoagulants.

VarmX's lead compound PseudoXa was inspired by a snake venom protein.